Skip to main content
SpringerLink
Log in

Nutrition and Chronic Kidney Disease

  • Chapter
  • First Online:
Handbook of Clinical Nutrition and Aging

Part of the book series: Nutrition and Health ((NH))

  • 2806 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

REFERENCES

  1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. Jama 2007; 298(17):2038–47.

    Article  PubMed  CAS  Google Scholar 

  2. Beddhu S, Allen-Brady K, Cheung AK, et al. Impact of renal failure on the risk of myocardial infarction and death. Kidney Int 2002; 62(5):1776–83.

    Article  PubMed  Google Scholar 

  3. USRDS 2006. Annual Data Report: http://www.usrds.org

  4. Melander O, von Wowern F, Frandsen E, et al. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma. J Hypertens 2007; 25(3):619–27.

    Article  PubMed  CAS  Google Scholar 

  5. Swift PA, Markandu ND, Sagnella GA, He FJ, MacGregor GA. Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial. Hypertension 2005; 46(2):308–12.

    Article  PubMed  CAS  Google Scholar 

  6. Fodor JG, Whitmore B, Leenen F, Larochelle P. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ 1999; 160(9 Suppl):S29–34.

    PubMed  CAS  Google Scholar 

  7. Gardner CD, Kiazand A, Alhassan S, et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA 2007; 297(9):969–77.

    Article  PubMed  CAS  Google Scholar 

  8. Skov AR, Toubro S, Bulow J, Krabbe K, Parving HH, Astrup A. Changes in renal function during weight loss induced by high vs low-protein low-fat diets in overweight subjects. Int J Obes Relat Metab Disord 1999; 23(11):1170–7.

    Article  PubMed  CAS  Google Scholar 

  9. Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994; 330(13):877–84.

    Article  PubMed  CAS  Google Scholar 

  10. Levey AS, Adler S, Caggiula AW, et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kidney Dis 1996; 27(5):652–63.

    Article  PubMed  CAS  Google Scholar 

  11. Kopple JD, Levey AS, Greene T, et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney Int 1997; 52(3):778–91.

    Article  PubMed  CAS  Google Scholar 

  12. Knight EL, Stampfer MJ, Hankinson SE, Spiegelman D, Curhan GC. The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency. Ann Intern Med 2003; 138(6):460–7.

    PubMed  Google Scholar 

  13. Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarod K, Holmen J. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis 2006; 47(3):396–405.

    Article  PubMed  Google Scholar 

  14. Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am J Kidney Dis 2005; 46(4):587–94.

    Article  PubMed  Google Scholar 

  15. Gelber RP, Kurth T, Kausz AT, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 2005; 46(5):871–80.

    Article  PubMed  Google Scholar 

  16. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144(1):21–8.

    PubMed  Google Scholar 

  17. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003; 14(6):1480–6.

    Article  PubMed  Google Scholar 

  18. Vogel JA, Franklin BA, Zalesin KC, et al. Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery. Am J Cardiol 2007; 99(2):222–6.

    Article  PubMed  Google Scholar 

  19. Navarro-Diaz M, Serra A, Romero R, et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol 2006; 17(12 Suppl 3):S213–7.

    Article  PubMed  Google Scholar 

  20. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16(7):2134–40.

    Article  PubMed  Google Scholar 

  21. Bastard JP, Jardel C, Delattre J, Hainque B, Bruckert E, Oberlin F. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation 1999; 99: 2221–2.

    PubMed  CAS  Google Scholar 

  22. Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 1997; 96(9):3042–7.

    Article  PubMed  CAS  Google Scholar 

  23. Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. Faseb J 1999; 13(10):1231–8.

    PubMed  CAS  Google Scholar 

  24. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996; 271(5249):665–8.

    Article  PubMed  CAS  Google Scholar 

  25. Nakajima J, Mogi M, Kage T, Chino T, Harada M. Hypertriglyceridemia associated with tumor necrosis factor-alpha in hamster cheek-pouch carcinogenesis. J Dent Res 1995; 74(9):1558–63.

    Article  PubMed  CAS  Google Scholar 

  26. Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003; 107(5):671–4.

    Article  PubMed  CAS  Google Scholar 

  27. Quehenberger P, Exner M, Sunder-Plassmann R, et al. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res 2002; 90(6):711–8.

    Article  PubMed  CAS  Google Scholar 

  28. Schneider JG, von Eynatten M, Schiekofer S, Nawroth PP, Dugi KA. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care 2005; 28(9):2181–6.

    Article  PubMed  CAS  Google Scholar 

  29. Stephens JM, Pekala PH. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem 1991; 266(32):21839–45.

    PubMed  CAS  Google Scholar 

  30. Tham DM, Martin-McNulty B, Wang YX, et al. Angiotensin II is associated with activation of NF-kappa B-mediated genes and downregulation of PPARs. Physiol Genomics 2002; 11(1):21–30.

    PubMed  CAS  Google Scholar 

  31. Verma S, Li SH, Wang CH, et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003; 108(6):736–40.

    Article  PubMed  CAS  Google Scholar 

  32. von Eynatten M, Schneider JG, Humpert PM, et al. Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care 2004; 27(12):2925–9.

    Article  Google Scholar 

  33. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115(5):1111–9.

    PubMed  CAS  Google Scholar 

  34. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB. Adiponectin–a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006; 8(3):264–80.

    Article  PubMed  CAS  Google Scholar 

  35. Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105(7):804–9.

    Article  PubMed  CAS  Google Scholar 

  36. Johansen KL, Young B, Kaysen GA, Chertow GM. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 2004; 80:324–32.

    PubMed  CAS  Google Scholar 

  37. Abbott KC, Glanton CW, Trespalacios FC, et al. Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int 2004; 65:597–605.

    Article  PubMed  Google Scholar 

  38. Aoyagi T, Naka H, Miyaji K, Hayakawa K, Ishikawa H, Hata M. Body mass index for chronic hemodialysis patients: stable hemodialysis and mortality. Int J Urol 2001; 8:S71–S5.

    Article  PubMed  CAS  Google Scholar 

  39. Beddhu S, Pappas LM, Ramkumar N, Samore M. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003; 14:2366–72.

    Article  PubMed  Google Scholar 

  40. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005; 81(3):543–54.

    PubMed  CAS  Google Scholar 

  41. Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 2005; 46:489–500.

    Article  PubMed  Google Scholar 

  42. Kopple JD. Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients. ASAIO J 1997; 43:246–50.

    PubMed  CAS  Google Scholar 

  43. Kutner NG, Zhang R. Body mass index as a predictor of continued survival in older chronic dialysis patients. Int Urol Nephrol 2001; 32:441–8.

    Article  PubMed  CAS  Google Scholar 

  44. Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW. Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2001; 16:2386–94.

    Article  PubMed  CAS  Google Scholar 

  45. Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 1998; 31:997–1006.

    Article  PubMed  CAS  Google Scholar 

  46. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002; 13:1061–6.

    PubMed  Google Scholar 

  47. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003; 42:864–81.

    Article  PubMed  Google Scholar 

  48. Nishizawa Y, Shoji T, Ishimura E, Inaba M, Morii H. Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia?. Am J Kidney Dis 2001; 38:S4–S7.

    Article  PubMed  CAS  Google Scholar 

  49. Yamauchi T, Kuno T, Takada H, Nagura Y, Kanmatsuse K, Takahashi S. The impact of visceral fat on multiple risk factors and carotid atherosclerosis in chronic haemodialysis patients. Nephrol Dial Transplant 2003; 18:1842–7.

    Article  PubMed  Google Scholar 

  50. Beddhu S, Pappas LM, Ramkumar N, Samore M. Malnutrition and atherosclerosis in dialysis patients. J Am Soc Nephrol 2004; 15:733–42.

    Article  PubMed  CAS  Google Scholar 

  51. Axelsson J, Qureshi RA, Suliman ME, et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 2004; 80:1222–9.

    PubMed  CAS  Google Scholar 

  52. Axelsson J, Qureshi AR, Heimburger O, Lindholm B, Stenvinkel P, Barany P. Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD. Am J Kidney Dis 2005; 46(4):628–34.

    Article  PubMed  CAS  Google Scholar 

  53. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342(20):1478–83.

    Article  PubMed  CAS  Google Scholar 

  54. Stompor T, Pasowicz M, Sullowicz W, et al. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 2003; 41:203–11.

    Article  PubMed  Google Scholar 

  55. Kwan BC, Murtaugh MA, Beddhu S. Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease. Clin J Am Soc Nephrol 2007; 2(5):992–8.

    Article  PubMed  Google Scholar 

  56. Kwan BC, Beddhu S. A story half untold: adiposity, adipokines and outcomes in dialysis population. Semin Dial 2007; 20(6):493–7.

    Article  PubMed  Google Scholar 

  57. Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2000; 35(6 Suppl 2):S1–140.

    Google Scholar 

  58. Mitch WE. Malnutrition: a frequent misdiagnosis for hemodialysis patients. J Clin Invest 2002; 110:437–9.

    PubMed  CAS  Google Scholar 

  59. Hara Y, May RC, Kelly RA, Mitch WE. Acidosis, not azotemia, stimulates branched-chain, amino acid catabolism in uremic rats. Kidney Int 1987 Dec; 32(6):808–14.

    Article  PubMed  CAS  Google Scholar 

  60. May RC, Kelly RA, Mitch WE. Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis. J Clin Invest 1987 Apr; 79(4):1099–103.

    Article  PubMed  CAS  Google Scholar 

  61. May RC, Bailey JL, Mitch WE, Masud T, England BK. Glucocorticoids and acidosis stimulate protein and amino acid catabolism in vivo. Kidney Int 1996 Mar; 49(3):679–83.

    Article  PubMed  CAS  Google Scholar 

  62. Goodman MN. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol 1991 260(5):E727–30.

    PubMed  CAS  Google Scholar 

  63. Goldberg AL, Kettelhut IC, Furuno K, Fagan JM, Baracos V. Activation of protein breakdown and prostaglandin E2 production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin 1 or other known monokines. J Clin Invest 1988; 81(5):1378–83.

    Article  PubMed  CAS  Google Scholar 

  64. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 1996; 335(25):1897–905.

    Article  PubMed  CAS  Google Scholar 

  65. Ahuja TS, Mitch WE. The evidence against malnutrition as a prominent problem for chronic dialysis patients. Semin Dial 2004 Nov–Dec; 17(6):427–31.

    Article  PubMed  Google Scholar 

  66. Pickering WP, Price SR, Bircher G, Marinovic AC, Mitch WE, Walls J. Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int 2002 Apr; 61(4):1286–92.

    Article  PubMed  CAS  Google Scholar 

  67. Pupim LB, Flakoll PJ, Brouillette JR, Levenhagen DK, Hakim RM, Ikizler TA. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest 2002 Aug; 110((4):483–92.

    PubMed  CAS  Google Scholar 

  68. Ikizler TA, Pupim LB, Brouillette JR, et al. Hemodialysis stimulates muscle and whole-body protein loss and alters substrate oxidation. Am J Physiol – Endocrinol Metab 2002; 282:E107–16.

    PubMed  CAS  Google Scholar 

  69. Kaysen GA, Greene T, Daugirdas JT, et al. Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients. Am J Kidney Dis 2003; 42(6):1200–11.

    Article  PubMed  CAS  Google Scholar 

  70. Goodman MN. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol 1991 May; 260(5 Pt 1):E727–30.

    PubMed  CAS  Google Scholar 

  71. Kaizu Y, Ohkawa S, Odamaki M, et al. Association between inflammatory mediators and muscle mass in long-term hemodialysis patients. Am J Kidney Dis 2003; 42:295–302.

    Article  PubMed  CAS  Google Scholar 

  72. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001; 38:1251–63.

    Article  PubMed  CAS  Google Scholar 

  73. Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999 May; 55(5):1899–911.

    Article  PubMed  CAS  Google Scholar 

  74. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000; 15:953–60.

    Article  PubMed  CAS  Google Scholar 

  75. Chertow GM, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK. Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 2004; 19(6):1489–96.

    Article  PubMed  Google Scholar 

  76. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12:2131–8.

    PubMed  CAS  Google Scholar 

  77. Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62(1):245–52.

    Article  PubMed  CAS  Google Scholar 

  78. Block GA, Spiegel DM, Ehrlich J, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005; 68(4):1815–24.

    Article  PubMed  CAS  Google Scholar 

  79. Suki WN, Zabaneh R, Cangiano JL, et al. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int 2007; 72(9):1130–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Salt Lake Veterans Affairs Healthcare System; Division of Nephrology & Hypertension, University of Utah School of Medicine, Salt Lake City, UT

    Srinivasan Beddhu

Authors
  1. Srinivasan Beddhu
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Center for the Study of Aging &, Human Development, Duke University Medical Center, Durham, 27710, USA

    Connie W. Bales

  2. Div. Gerontology, Geriatrics &, Palliative Medicine, University of Alabama, Birmingham, 19th Street South 933, Birmingham, 35294, USA

    Christine S. Ritchie

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Beddhu, S. (2009). Nutrition and Chronic Kidney Disease. In: Bales, C., Ritchie, C. (eds) Handbook of Clinical Nutrition and Aging. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-385-5_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-385-5_21

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-384-8

  • Online ISBN: 978-1-60327-385-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation